Abstract
Background
Reverse shoulder arthroplasty (RSA) is a common treatment of a variety of disabling shoulder conditions. The purpose of this study was to determine revision-free survivorship after RSA using a medialized glenoid and lateralized onlay-type humerus implant and to identify etiologies of revision.
Methods
All RSAs performed using the Comprehensive® Reverse Shoulder System (Zimmer Biomet, Inc.; Warsaw, IN, USA) at one institution from 2008 to 2014 were identified through a retrospective review. Charts were reviewed to determine whether the RSA was a primary or revision surgery. Patients were contacted by telephone, and survivorship was defined as no subsequent surgery after RSA. Of the 526 RSAs performed, responses were obtained from 403 patients (77%). A Kaplan–Meier analysis was performed to determine survivorship over time. A χ2 test was used to determine differences between revision rates after RSA.
Results
Minimum follow-up was 3 years, and average follow-up was 4.83 ± 1.60 years. Survivorship was 96% at 2 years and 93% at 5 years after RSA. Revisions were performed for instability (n = 8), humeral tray-taper junction failure (n = 5), acute fracture (n = 4), infection (n = 3), glenoid loosening (n = 3), osteolysis (n = 1), or notching (n = 1). Fourteen of the 151 patients (9.2%) who had surgery prior to RSA required revision after RSA. Having shoulder surgery prior to RSA was associated with higher rates of subsequent revision after RSA.
Conclusion
Overall, survivorship after RSA using a medialized glenoid and lateralized onlay-type humerus RSA is high, and prostheses implanted in native shoulders have lower rates of revision at midterm follow-up. Instability (1.9%) was the most common reason for revision.
Similar content being viewed by others
References
Bacle G, Nové-Josserand L, Garaud P, Walch G. Long-term outcomes of reverse total shoulder arthroplasty: a follow-up of a previous study. J Bone Joint Surg Am. 2017;99(6):454–461.
Edwards TB, Williams MD, Labriola JE, Elkousy HA, Gartsman GM, O’Connor DP. Subscapularis insufficiency and the risk of shoulder dislocation after reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2009;18(6):892–896.
Favard L, Levigne C, Nerot C, Gerber C, De Wilde L, Mole D. Reverse prostheses in arthropathies with cuff tear: are survivorship and function maintained over time? Clin Orthop Relat Res. 2011;469(9):2469–2475.
Frankle M, Siegal S, Pupello D, Saleem A, Mighell M, Vasey M. The reverse shoulder prosthesis for glenohumeral arthritis associated with severe rotator cuff deficiency: a minimum two-year follow-up study of sixty patients. J Bone Joint Surg Am. 2005;87(8):1697–1705.
Giles JW, Langohr GDG, Johnson JA, Athwal GS. Implant design variations in reverse total shoulder arthroplasty influence the required deltoid force and resultant joint load. Clin Orthop Relat Res. 2015;473(11):3615–3626.
Grammont P, Baulot E. Delta shoulder prosthesis for rotator cuff rupture. Orthopedics 1993;16(1):65–68.
Guery J, Favard L, Sirveaux F, Oudet D, Mole D, Walch G. Reverse total shoulder arthroplasty: survivorship analysis of eighty replacements followed for five to ten years. J Bone Joint Surg Am . 2006;88(8):1742–1747.
Levy J, Frankle M, Mighell M, Pupello D. The use of the reverse shoulder prosthesis for the treatment of failed hemiarthroplasty for proximal humeral fracture. J Bone Joint Surg Am. 2007;89(2):292–300.
Liou W, Yang Y, Petersen-Fitts GR, Lombardo DJ, Stine S, Sabesan VJ. Effect of lateralized design on muscle and joint reaction forces for reverse shoulder arthroplasty. J Shoulder Elbow Surg. 2017;26(4):564–572.
McDonald LS, Dines JS, Chin C, Warren RF, Dines DM. Humeral tray-taper failure in modular reverse total shoulder arthroplasty. HSS Journal. 2016;12(1):8–12.
Mizuno N, Denard PJ, Raiss P, Walch G. Reverse total shoulder arthroplasty for primary glenohumeral osteoarthritis in patients with a biconcave glenoid. J Bone Joint Surg Am. 2013;95(14):1297–1304.
Mulieri P, Dunning P, Klein S, Pupello D, Frankle M. Reverse shoulder arthroplasty for the treatment of irreparable rotator cuff tear without glenohumeral arthritis. J Bone Joint Surg Am . 2010;92(15):2544–2556.
Rittmeister M, Kerschbaumer F. Grammont reverse total shoulder arthroplasty in patients with rheumatoid arthritis and nonreconstructible rotator cuff lesions. J Shoulder Elbow Surg. 2001;10(1):17–22.
Saltzman BM, Chalmers PN, Gupta AK, Romeo AA, Nicholson GP. Complication rates comparing primary with revision reverse total shoulder arthroplasty. J Shoulder Elbow Surg. 2014;23(11):1647–1654.
Sirveaux F, Favard L, Oudet D, Huquet D, Walch G, Mole D. Grammont inverted total shoulder arthroplasty in the treatment of glenohumeral osteoarthritis with massive rupture of the cuff: results of a multicentre study of 80 shoulders. J Bone Joint Surg Br . 2004;86(3):388–395.
US Food and Drug Administration. Zimmer Biomet recalls Comprehensive Reverse Shoulder due to a high fracture rate. December 15, 2016. Available from https://www.fda.gov/medicaldevices/safety/listofrecalls/ucm541862.htm .
Wall B, O’Connor DP, Edwards TB, Nové-Josserand L, Walch G. Reverse total shoulder arthroplasty: a review of results according to etiology. J Bone Joint Surg Am. 2007;89(7):1476–1485.
Werner C, Steinmann P, Gilbart M, Gerber C. Treatment of painful pseudoparesis due to irreparable rotator cuff dysfunction with the Delta III reverse-ball-and-socket total shoulder prosthesis. J Bone Joint Surg Am . 2005;87(7):1476–1486.
Werner BC, Wong AC, Mahony GT, et al. Clinical outcomes after reverse shoulder arthroplasty with and without subscapularis repair: the importance of considering glenosphere lateralization. J Am Acad Orthop Surg. 2018;26(5):e114–e119.
Young AA, Smith MM, Bacle G, Moraga C, Walch G. Early results of reverse shoulder arthroplasty in patients with rheumatoid arthritis. J Bone Joint Surg Am . 2011;93(20):1915–1923.
Zumstein MA, Pinedo M, Old J, Boileau P. Problems, complications, reoperations, and revisions in reverse total shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg. 2011;20(1):146–157.
Funding
The authors received funding from Zimmer Biomet in support of their research and preparation of this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Ryan C. Rauck, MD, Eric P. Eck, BS, Brenda Chang, MS, Edward V. Craig, MD, Joshua S. Dines, MD, David M. Dines, MD, Russell F. Warren, MD, and Lawrence V. Gulotta, MD, all report receiving grant funding from Zimmer Biomet in support of this research and this article. In addition, Edward V. Craig, MD, reports royalties from Zimmer Biomet and from Wolters Kluwer, outside the submitted work. Joshua S. Dines, MD, reports personal fees and grants from Arthrex, editorial board membership from American Journal of Orthopaedics, and a patent with royalties paid from Conmed, outside the submitted work. David M. Dines, MD, reports financial or material support and royalties from Zimmer Biomet, during the conduct of the study, plus personal fees from Wright Medical Technology, Inc., outside the submitted work. Russell F. Warren, MD, reports stock or stock options from Ivy Sports Medicine and Orthonet and royalties from Zimmer Biomet and Smith & Nephew, outside the submitted work. Lawrence V. Gulotta, MD, reports personal fees as a speaker from Zimmer Biomet, during the conduct of the study.
Human/Animal Rights
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2013.
Informed Consent
Informed consent was waived from all patients for being included in this study.
Required Author Forms
Disclosure forms provided by the authors are available with the online version of this article.
Additional information
Level of Evidence: Level IV: Therapeutic Retrospective Cohort Study
Rights and permissions
About this article
Cite this article
Rauck, R.C., Eck, E.P., Chang, B. et al. Survivorship of a Medialized Glenoid and Lateralized Onlay Humerus Reverse Shoulder Arthroplasty Is High at Midterm Follow-up. HSS Jrnl 16 (Suppl 2), 293–299 (2020). https://doi.org/10.1007/s11420-019-09721-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11420-019-09721-y